Rx Drug News

Complete Archives

2010 September
- Cancer drug points way to new Alzheimer’s approach
- Diabetes drug may keep lung cancer at bay
2010 August
- Scientists suggest fresh look at psychedelic drugs
- U.S. proposes withdrawal of Shire hypotension drug
- FDA approves new “morning-after” pill
- Acetaminophen tied to childhood wheezing and allergies
- Anti-seizure drug Lamictal may cause meningitis: FDA
- Vertex hep C drug works on many in 24 weeks: study
- Little evidence antidepressants helpful for autism
- New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
- Genetic Testing Best Left Out of Pharmacies/Internet, SLU Geneticist Warns
- New drug shown safe, effective in treating hereditary angioedema
- Solving the mystery of bone loss from drug for epilepsy and bipolar disorder
- Etoricoxib Is Effective for Postoperative Pain
2010 July
- Editor changes industry-backed tanning pill study
- FDA warns of pneumonia risk with antibiotic
- Popular diabetes drugs associated with fractures in type 2 diabetic patients
- Multiple Sclerosis - antihypertensive drug ameliorate inflammation in the brain
- Predicting drug responsiveness in cancer patients
- Non-Human Sugar in Biotech Drugs Causes Inflamation
- Use of sleep disorder drug could be limited in Europe
- Stopping anemia drug may be wiser than reducing dose to normalize hemoglobin levels
- 3 Georgian leaders sign Vienna Declaration, strengthen call for science-based drug policy
- New J&J plant woes include Pepcid flavor mixups
- Study raises hope for safer diabetes drugs
- U.S. panel rejects Avastin for breast cancer
- Some cos reluctant to join AIDS drug pool for poor
- FDA accepts historical controls for epilepsy monotherapy studies
- Antibiotics for the Prevention of Malaria
- New study backs Avastin in lung cancer
- U.N. urged to probe U.S. trade stance on generic drugs
- NIH’s Anthony S. Fauci to discuss early HIV infection and a novel target for HIV vaccine development
- Whooping cough vaccine not linked to seizures
- FDA staff question Roche drug breast cancer data
- Cancer Drugs May Help Stop Major Parasite
- Dissolving Microneedles Improve Flu Vaccine Delivery
- Future HIV vaccines: If we build it, will they come?
- US panel hears final pleas on Glaxo diabetes drug
- U.S. cancer group endorses newer breast cancer drugs
- Lawsuits may reveal more Avandia data
- Fat pill works; safety a concern: FDA staff
- Experimental obesity drug avoids brain effects that troubled predecessors
- Why Parkinson’s disease patients aren’t walking tall
- Johnson & Johnson sued over drug recall
- EU and U.S. ask if Avandia has a future
- Scientists use computer algorithms to develop seasonal flu vaccines
- Tracy Named Dean of UK College of Pharmacy
- Expanded Tylenol recall aggravates J&J headache
- New obesity pills try to shed past problems
- Drug study shows improvement in major orthopedic surgery care
- Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
- Drug firms to help WADA identify new doping compounds
- Glucosamine doesn’t ease low back pain: study
- UK health body rejects kidney cancer drug Afinitor
- US House votes to ban some drug patent settlements
- Cutting drug prices hampers new development: study
2010 June
- Tougher review foreseen for Glaxo diabetes drug
- Delhi doctors begin trials for new diabetes drug
- Tranzyme Pharma’s gastroparesis drug for diabetes patients meets phase II trial goals
- Study finds no link between diabetes drug rosiglitazone and increased rate of heart attack
- New diabetes drug effective in study
- No pancreatitis risk seen in Byetta, Januvia drugs
- Former tennis star Capriati treated for overdose
- P&G recalls nasal spray sold in U.S. stores
- No shortage of kids’ medicines seen: FDA
- US FDA panel to review Orexigen obesity drug
- MAP Pharma reports positive migraine drug data
- Antihypertensive drugs may offer protection against Alzheimer’s
- Low-dose polio vaccine effective: study
- Leukemia drug pulled from U.S. market
- Top court rejects Pfizer punitive damages appeal
- Europe’s drugmakers beat U.S. on access for poor
- FDA fines Red Cross $16 million for safety lapses
- Campbell recalls 3 varieties of SpaghettiOs in the U.S.
- Feared Side Effect of Alzheimer’s Drugs Is Unlikely
- Neurocrine, Boehringer to develop diabetes drug
- UK watchdog rejects long-term use of lung cancer pill
- Lilly reports positive data from new diabetes drug trial
- FDA, NIH lay out roadmap for personalized medicine
- U.S. FDA to post risk summaries for newer drugs
- J&J recalls Benadryl, Tylenol overlooked in January
- FDA staff question female sex-drive pill data
- Drug-resistant bugs on rise globally: report
- Cheap blood drug “could save 100,000 lives a year”
- Drugs linked to cataracts, behaviors can delay them
- Documents show J&J bought Motrin before recall
- Unpublished FDA study says diabetes drug Avandia should be withdrawn
- FDA says it will investigate potential heart risks of hypertension drug Benicar
- Metformin Not Protective Following Prostate Cancer Surgery in Patients With Diabetes
- Popular Cancer Drug Can Cause Kidney Damage
- Widely Used Cancer Drug May Increase Risk for Proteinuria in Patients
- Researchers Modify Yellow Fever Vaccine to Fight Malaria
- New Progress for HIV/AIDS Therapeutic Vaccine As First Trial Moves Forward
- FDA looking into blood pressure drug’s death risk
- FDA official attacks safety of diabetes drug
- House panel cites J&J response in recall probe
- Texas Tech Enters License Agreement for Technology That Combats Antibiotic-Resistant Bacteria
- FDA staff eyes safety of MS drug
- US FDA needs vision, and a few more teeth - report
- FDA should adopt risk-based approach to food safety

Subscribe to the "News" RSS Feed

TOP 

Cancer drug points way to…
An altered version of the cancer drug Gleevec could…
Diabetes drug may keep lung…
The common diabetes drug metformin may hold promise as a…
Scientists suggest fresh look at…
Mind-altering drugs like LSD, ketamine or magic mushrooms could be…
U.S. proposes withdrawal of Shire…
U.S. health officials for the first time have proposed withdrawing…
FDA approves new “morning-after” pill
Health officials on Friday approved a new, longer lasting…
Acetaminophen tied to childhood wheezing…
A pair of studies suggests that the common painkiller acetaminophen—better…
Anti-seizure drug Lamictal may cause…
GlaxoSmithKline Plc’s anti-seizure drug Lamictal can cause a brain inflammation…
Vertex hep C drug works…
A study of Vertex Pharmaceuticals Inc.’s high profile experimental…
Little evidence antidepressants helpful for…
While antidepressants are commonly given to people with autism, there…
New anti-viral drug shows promise…
Adding a direct acting anti-viral drug to the standard treatment…
Genetic Testing Best Left Out…
In the age of the Internet, where cybercondriacs are…
New drug shown safe, effective…
Clinical trials from two international research teams have shown that…
Solving the mystery of bone…
Scientists are reporting a possible explanation for the bone loss…
Etoricoxib Is Effective for Postoperative…
For patients with moderate pain after foot surgery, the cyclo-oxygenase…
Editor changes industry-backed tanning pill…
A journal editor has scrubbed a line supporting the…

About Us | Privacy Policy | Terms of Use | Contact Us

© 2007 RxDrug News 1999-2008. All rights reserved